Current Appointments & Affiliations
Professor of Neurology
·
2018 - Present
Neurology, Neuromuscular Disease,
Neurology
Director of EMG Lab Services in the Department of Neurology
·
2006 - Present
Neurology,
Clinical Science Departments
Division Chief, Neuromuscular Disease in the Department of Neurology
·
2015 - Present
Neurology,
Clinical Science Departments
Recent Publications
Serum fibrinogen is not elevated in patients with myasthenia gravis.
Journal Article Sci Rep · April 15, 2025 Myasthenia gravis (MG) is an autoimmune, autoantibody-mediated disease characterized by fatigable weakness of skeletal muscles. MG is a heterogeneous disease that currently lacks a robust biomarker for diagnosing all subtypes. Residual serum fibrinogen was ... Full text Open Access Link to item CiteImmune dysregulation in chronic inflammatory demyelinating polyneuropathy.
Journal Article J Neuroimmunol · June 15, 2024 OBJECTIVE: Chronic inflammatory demyelinating polyneuropathy (CIDP) is an autoimmune disorder of the peripheral nerves with an incompletely understood underlying pathophysiology. This investigation focused on defining B and T cell frequencies, T cell funct ... Full text Link to item CiteComparative effectiveness of azathioprine and mycophenolate mofetil for myasthenia gravis (PROMISE-MG): a prospective cohort study.
Journal Article Lancet Neurol · March 2024 BACKGROUND: Myasthenia gravis is an autoimmune disorder of the neuromuscular junction. Treatment typically includes symptomatic oral cholinesterase inhibitors, immunosuppression, and immunomodulation. In addition to corticosteroids, azathioprine and mycoph ... Full text Link to item CiteRecent Grants
DNA08: ARGX-113-2315
Clinical TrialPrincipal Investigator · Awarded by Argenx BVBA · 2025 - 2030DNA05 Argenx_ARGX-113-2308: A randomized, double-blinded, placebo-controlled, phase 3, parallel group design study evaluating the efficacy and safety of efgartigimod IV in adult participants with acetylcholine receptor binding antibody (AChR-Ab)
Clinical TrialPrincipal Investigator · Awarded by Argenx BVBA · 2024 - 2029Alexion ALXN1720-MG-301
Clinical TrialPrincipal Investigator · Awarded by Alexion Pharmaceuticals, Inc. · 2023 - 2028View All Grants
Education, Training & Certifications
University of Illinois ·
1989
M.D.